October 15-16 2014
Hyatt at The Bellevue
Adverse events are the pillars of pharmacovigilance and safety operations as we know them. They have been the drivers for developing safety databases, risk management plans, risk evaluation and mitigation strategies (REMS), benefit-risk assessments and periodic reports. Their collection and reporting has been instrumental in leading to preventative actions for marketing better and safer drugs.
The Adverse Event Reporting and Safety Strategies Summit dives into the different ramifications of adverse event reporting in the context of benefit-risk assessments, real world data, risk management plans, signal detection, periodic reporting and solicited/unsolicited reports. The summit illustrates how different life sciences companies are working towards a better prevention, detection and assessment of adverse reactions to drive reporting and impact drug safety profiles.